Poly Pharmaceuticals Recalls Poly-Tussin AC Liquid Due to Labeling and Specification Issues
Poly Pharmaceuticals is recalling 208 bottles of Poly-Tussin AC Liquid because phenylephrine levels are below specifications and the label inaccurately states 'Rx Only'.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences, and the issues are primarily related to labeling and minor specification deviations.
Plain-English summary
Poly Pharmaceuticals, Inc. is recalling 208 bottles of Poly-Tussin AC Liquid, 16 fl oz. (473 mL) bottles. The product is a prescription cough syrup containing brompheniramine maleate, codeine phosphate, and phenylephrine HCl. The recall was initiated because the phenylephrine content is below monograph specifications and the label inaccurately contains the wording "Rx Only".
The recalled product is identified by Lot # 04413 and an expiration date of 02/15. It was distributed nationwide in the United States. The product was manufactured by Great Southern Laboratories in Houston, TX, and distributed for Poly Pharmaceuticals in Mobile, AL.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for guidance. The FDA has classified this recall as Class III, indicating that use of or exposure to the violative product is not likely to cause adverse health consequences.
The recalled product
- Product
- POLY-TUSSIN AC LIQUID, Each 5 mL (1 teaspoonful) contains: Brompheniramine Maleate 4 mg, Codeine Phosphate 10 mg, Phenylephrine HCl 7.5 mg, 16 fl oz. (473 mL) Bottle, Rx Only. Manufactured by: Great Southern Laboratories, Houston, TX 77099, Distributed for: Poly Pharmaceuticals,
- Manufacturer
- Poly Pharmaceuticals, Inc
- Category
- Drug — Cough and Cold Medication
- Hazard
- Affected units
- 208
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 04413
- Expiry: 02/15
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Poly Pharmaceuticals, Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Poly Pharmaceuticals, Inc
See all →- LowPoly Pharmaceuticals Recalls Lortuss Ex Due to Labeling and Specification Issues
FDA (Drugs) · 2014-07-23
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02